» Articles » PMID: 21195583

GRADE Guidelines: 1. Introduction-GRADE Evidence Profiles and Summary of Findings Tables

Overview
Publisher Elsevier
Specialty Public Health
Date 2011 Jan 4
PMID 21195583
Citations 3600
Authors
Affiliations
Soon will be listed here.
Abstract

This article is the first of a series providing guidance for use of the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system of rating quality of evidence and grading strength of recommendations in systematic reviews, health technology assessments (HTAs), and clinical practice guidelines addressing alternative management options. The GRADE process begins with asking an explicit question, including specification of all important outcomes. After the evidence is collected and summarized, GRADE provides explicit criteria for rating the quality of evidence that include study design, risk of bias, imprecision, inconsistency, indirectness, and magnitude of effect. Recommendations are characterized as strong or weak (alternative terms conditional or discretionary) according to the quality of the supporting evidence and the balance between desirable and undesirable consequences of the alternative management options. GRADE suggests summarizing evidence in succinct, transparent, and informative summary of findings tables that show the quality of evidence and the magnitude of relative and absolute effects for each important outcome and/or as evidence profiles that provide, in addition, detailed information about the reason for the quality of evidence rating. Subsequent articles in this series will address GRADE's approach to formulating questions, assessing quality of evidence, and developing recommendations.

Citing Articles

The effectiveness of instrument-assisted soft tissue mobilization on pain and function in patients with musculoskeletal disorders: a systematic review and meta-analysis.

Tang S, Sheng L, Wei X, Liang M, Xia J, Chen J BMC Musculoskelet Disord. 2025; 26(1):257.

PMID: 40087631 DOI: 10.1186/s12891-025-08492-4.


Efficacy and safety of Chinese classical prescriptions for dilated cardiomyopathy: a systematic review and Bayesian network meta-analysis.

Tao S, Yu L, Li J, Wu J, Xia X, Li Y Syst Rev. 2025; 14(1):59.

PMID: 40069806 PMC: 11895376. DOI: 10.1186/s13643-025-02802-6.


Emergency Department Programs to Support Medication Safety in Older Adults: A Systematic Review and Meta-Analysis.

Skains R, Hayes J, Selman K, Zhang Y, Thatphet P, Toda K JAMA Netw Open. 2025; 8(3):e250814.

PMID: 40067297 PMC: 11897843. DOI: 10.1001/jamanetworkopen.2025.0814.


Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors for Treatment of Anemia in Chronic Kidney Disease: Guidelines for South Asia.

Abraham A, Almeida A, Bhalla A, Chaudury A, Dutta A, Gupta A Indian J Nephrol. 2025; 35(2):129-167.

PMID: 40060060 PMC: 11883314. DOI: 10.25259/ijn_389_23.


Comparison of the efficacy and safety of docetaxel plus capecitabine versus docetaxel plus epirubicin for human epidermal growth factor 2 -negative breast cancer: a meta-analysis.

Wu J, Wang Z, Fu Y BMC Womens Health. 2025; 25(1):104.

PMID: 40055784 PMC: 11887160. DOI: 10.1186/s12905-025-03628-z.